VISFO
Success story

Designing a trial with the finish line in mind

Maximising the chances of becoming a new standard of care, before a single patient is enrolled.
Credit card mockupColorful gradient

At a glance

Pharmaceutical

Market Access

Value communication

Initial delivery in 4 weeks

Delivered through HelixAI

Ongoing engagement

"With VISFO’s precision intelligence and collaborative approach, our team ensures you have the right insights, at the right time, to make the best possible strategic decisions."

Dr. Rachael Hagan
Director of Product

“The biggest mistake in trial design is thinking success ends with regulatory approval. From the start, we shaped this Phase 3 study around the full asset journey. We aligned endpoints that satisfy regulators with outcomes that matter to HTA bodies, and chose comparators that reflect the evolving standard of care. When strategy and science move together, you get trials that stand up in the real world.”

Dr. Louise Street-Docherty
VP Strategic Intelligence

“The biggest mistake in trial design is thinking success ends with regulatory approval. From the start, we shaped this Phase 3 study around the full asset journey. We aligned endpoints that satisfy regulators with outcomes that matter to HTA bodies, and chose comparators that reflect the evolving standard of care. When strategy and science move together, you get trials that stand up in the real world.”

Dr. Max Nobile
CEO

“With deep research roots and peer-reviewed expertise in digital insight, we help teams cut through noise to uncover what truly shapes outcomes, ensuring every decision is informed by what matters most.”

Dr Adam Poulston
Director of Engineering

“With deep research roots and peer-reviewed expertise in digital insight, we help teams cut through noise to uncover what truly shapes outcomes, ensuring every decision is informed by what matters most.”

Dr. Simon Leigh
Director of Research & Insights
Designing a trial with the finish line in mind

Built on data, shaped by expertise

Combining sharp data science, deep industry knowledge, and the tools to move fast and make it stick

The challenge

Our client was preparing to enter Phase 3 with a new oncology asset but lacked the strategic insight to shape a trial that would satisfy both regulators and payers. With limited experience in this specific indication, they needed to define the right endpoints, select the most relevant comparators, and understand the evolving competitive field. The goal was simple: design a trial that leads to approval and real-world adoption.

The analysis

We started with a rapid but thorough appraisal of the indication. This included treatment guidelines, clinical expectations, and the drivers behind recent approvals. Drawing on internal expertise, clinical trial databases, HTA records, and global regulatory filings, our consultants mapped the full landscape. We then examined the trajectory of emerging competitors and uncovered patterns in how recent trials had succeeded or failed. These findings were translated into clear, strategic insights for our client’s trial design.

The solution

We delivered a focused set of strategic recommendations hosted in our secure delivery portal for easy access and collaboration. These included relevant comparators backed by clinical guidelines, a rationale for endpoints supported by regulatory and payer decisions, and a competitor map showing exactly where our client’s asset could stand out. By identifying what matters most to decision makers, we helped them design a trial that would withstand scrutiny and support a strong value proposition.

The value to the client

Our client moved forward with confidence. They had a well-structured trial design, grounded in clinical and commercial logic. The insights helped them make informed trade-offs, articulate their strategy, and prepare for the next phase of development with conviction.

Ongoing support

To ensure lasting value, we transformed the key insights into an interactive knowledge base. This tool now supports their teams with real-time competitor updates, dynamic trial tracking, and a place to store and revisit regulatory intelligence as the landscape evolves. The strategy continues to adapt as the asset progresses, without needing to start from scratch.

Build your solution

Take a guided walkthrough of how we solve complex challenges, step by step. Just tell us what you’re facing, and we’ll show you how data science, expert insight, and software come together to deliver lasting results.
Dashboard mockupiPhone mockup
Testimonals

What our clients say about us

"This is allowing me to answer questions I didn’t even know I had"
Medical Affairs Director
"I haven't seen anything like it with any other consulting group, ever."
VP Market Access & Reimbursement
"Thank you VISFO, this is incredible value for money"
Global Market Access Director
"The stakeholder mapping means I know how to resource my MSLs"
US Medical New Product Planning
"You have demonstrated all that I thought wasn’t possible"
Senior Director
This is allowing me to answer questions I didn’t even know I had!”
Medical Affairs Director
"Thank you VISFO, this is incredible value for money."
Global Market Access Director
"The stakeholder mapping means I know how to resource my MSLs."
US Medical New Product Planning
"You have demonstrated all that I thought wasn’t possible."
Senior Director